Sundar PichaiSundar Pichai earned $164M in 2023

Terrence A. Duffy is the CEO and Chairman of CME Group, a major player in the derivatives marketplace. Under his leadership, CME Group has seen impressive growth, notably a 25% increase in stock price in 2023, driving a total shareholder...

Quick Links
C

Terrence A. Duffy

CEO of CME Group

Education

Bachelor's degree from University of Wisconsin-Whitewater

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Financial Services

Born

January 1, 1963 - 62 years ago

CEO of CME Group for

8 years 3 months (Jan 2017 - Present)

Previous Experience

Executive Chairman since 2006, Chairman from 2002 to 2006

Holdings

See how much did Terrence A. Duffy make over time.

As of 2023, Terrence A. Duffy has a considerable stake in CME Group, with vested stocks valued at approximately $11.86 million. His holdings saw fluctuations consistent with the company’s performance in the stock market. In 2021, he earned a significant...

Total Stock Sold

$88.25M

CME

$88.25M

540,520 CME shares

What if they kept their stock?

If Terrence A. Duffy didn't sell their stock, today they would have:
Extra CME540,520 shares worth $98.61M.
This is 11.74% and $10.36M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Terrence A. Duffy.

CME

$23.33M

CME at $259.18/share

Mar 11, 2025

Sale

CME

$6.00M

CME at $218.53/share

Sep 16, 2024

Received

CME

$8.42M

CME at $210.39/share

Apr 29, 2024

Sale

CME

$9.87M

CME at $217.50/share

Mar 15, 2024

Received

CME

$6.00M

CME at $206.82/share

Sep 15, 2023

Received

CME

$6.12M

CME at $203.95/share

Aug 18, 2023

Sale

CME

31,452 shares

CME

Sep 15, 2022

Received

CME

$2.43M

CME at $232.00/share

Mar 15, 2022

Received

CME

$88.81K

CME at $222.02/share

Nov 5, 2021

Purchase

CME

$352.32K

CME at $220.20/share

Nov 4, 2021

Purchase

Compensation History

See how much did Terrence A. Duffy make over time.

Terrence A. Duffy's compensation in 2022 totaled $10.38 million, combining a base salary of $2 million with a performance bonus of over $7.7 million for exceeding cash earnings targets by 19%. His compensation structure is quite strategic: it aligns with company performance, reflecting a philosophy that rewards executives for achieving growth and shareholder value. The bonus was set at 196% of the target opportunity, indicating a strong benchmark for success. Additionally, he received vested stock worth nearly $11.86 million, solidifying his commitment to the company’s future. Despite facing criticism from shareholders about previous pay votes, Duffy has worked to enhance engagement and foster a more transparent dialogue regarding compensation, ensuring that his interests are well-aligned with those of CME Group’s stakeholders.

Year

2022

Total Compensation

$22.23M

Salary

$2.00M

Board Justification

CME Group's compensation philosophy is to align executive compensation with company performance and shareholder interests. The program is designed to attract and retain top talent, motivate executives to achieve strategic goals, and reward financial performance without encouraging excessive risk-taking.

Bonus

$7.77M

Board Justification

The annual bonus for Terrence A. Duffy was based on the achievement of cash earnings at 119.2% of the target level performance. The bonus was calculated as 196% of the target bonus opportunity, which was set at 200% of his base salary. The bonus was awarded without any additional discretion applied by the compensation committee.

Other

$606.01K

Board Justification

Other compensation includes 401(k) company contributions, supplemental plan contributions, and life insurance premiums paid by the company.

Restricted Stock

$11.86M(165.74K Restricted Stock)

Board Justification

The vested stock includes restricted stock awards that vested on December 31, 2022, as per the terms of Mr. Duffy's employment agreement.

Performance Metrics

The primary performance metric for determining the CEO's compensation in 2022 was cash earnings, which is a key component for measuring the company's growth and is used for determining regular quarterly dividend payments.

Other CME Group CEOs

Here are other CEOs of CME Group